1,900
Participants
Start Date
September 25, 2023
Primary Completion Date
June 7, 2024
Study Completion Date
June 7, 2024
Placebo
0.9% sodium chloride (normal saline) injection
mRNA-1345
Suspension for injection
Fluzone HD
Suspension for injection
DM Clinical Research - Philadelphia, Philadelphia
Trial Management Associates, LLC, Wilmington
Spartanburg Medical Research, Spartanburg
Clinical Research Atlanta/Headlands, Stockbridge
Headlands Research - Orlando, Orlando
Neoclinical Research, Hialeah
South Florida Research Center, Inc., Miami
Suncoast Research Associates, LLC, Miami
Health Awareness INC, Jupiter
New Tampa Health, Inc, Tampa
Delricht Moyer, Hendersonville
Delricht Research at Gulfport Memorial, Gulfport
Centricity Research, Columbus
Synexus AES - Akron, Akron
DM Clinical Research - Southfield, Southfield
DM Clinical Research- River Forest, River Forest
Delricht Research, Springfield
Be Well Clinical Studies, LLC, Lincoln
Velocity Clinical Research-Norfolk, Norfolk
DelRicht Research @ Neighborhood Health, Prairieville
Velocity Clinical Research-Baton Rouge, Baton Rouge
Delricht Tate, Tulsa
DELRICHT RESEARCH at ZOMNIR FAMILY MEDICINE, McKinney
Javara Inc. /Privia Medical Group Gulf Coast, PLLC, Sugar Land
DM Clinical Research - Houston, Houston
DM Clinical Research, Tomball
Bingham Memorial Hospital, Blackfoot
Scottsdale Clinical Trials, Scottsdale
Headlands Research, Inc., Scottsdale
Peninsula Research Associates (PRA), Rolling Hills Estates
Acclaim Clinical Research, San Diego
Artemis Institute for Clinical Research, Riverside
West Coast Research LLC, Dublin
DM Clinical Research - Brookline, Brookline
ModernaTX, Inc.
INDUSTRY